These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35708144)

  • 1. Confirmatory efficacy testing for individual dose-placebo comparisons using serial gatekeeping procedure in dose-finding trials with multiple comparison procedures-modeling.
    Yamaguchi Y; Sugitani T; Yoshida S; Maruo K
    Pharm Stat; 2022 Nov; 21(6):1309-1323. PubMed ID: 35708144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-ranging design and analysis methods to identify the minimum effective dose (MED).
    Zhou Y; Chen S; Sullivan D; Li Y; Zhang Y; Xie W; Zhang H; Tang Y; Wang L; Hartford A; Yang B
    Contemp Clin Trials; 2017 Dec; 63():59-66. PubMed ID: 28818433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cLRT-Mod: An efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertainty.
    Buatois S; Ueckert S; Frey N; Retout S; Mentré F
    Stat Med; 2021 May; 40(10):2435-2451. PubMed ID: 33650148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiple comparison procedure for dose-finding trials with subpopulations.
    Thomas M; Bornkamp B; Posch M; König F
    Biom J; 2020 Jan; 62(1):53-68. PubMed ID: 31544265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials.
    Ohlssen D; Racine A
    J Biopharm Stat; 2015; 25(1):137-56. PubMed ID: 24836192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing effect of a drug using multiple nested models for the dose-response.
    Baayen C; Hougaard P; Pipper CB
    Biometrics; 2015 Jun; 71(2):417-27. PubMed ID: 25660353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adaptive two-stage dose-response design method for establishing proof of concept.
    Franchetti Y; Anderson SJ; Sampson AR
    J Biopharm Stat; 2013; 23(5):1124-54. PubMed ID: 23957520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different approaches for dose response analysis.
    Saha S; Brannath W
    Biom J; 2019 Jan; 61(1):83-100. PubMed ID: 30203492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power and sample size for dose-finding studies with survival endpoints under model uncertainty.
    Deng Q; Bai X; Liu D; Roy D; Ying Z; Lin DY
    Biometrics; 2019 Mar; 75(1):308-314. PubMed ID: 30203467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical considerations on implementing the MCP-Mod method for binary endpoints in clinical trials.
    Chen J; Liu T
    Contemp Clin Trials Commun; 2020 Sep; 19():100641. PubMed ID: 32875139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures.
    Ouyang J; Zhang P; Carroll KJ; Lee J; Koch G
    J Biopharm Stat; 2020 Jul; 30(4):593-606. PubMed ID: 31829826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters.
    Soulakova JN
    J Biopharm Stat; 2011 Jul; 21(4):635-49. PubMed ID: 21516561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General multistage gatekeeping procedures.
    Dmitrienko A; Tamhane AC; Wiens BL
    Biom J; 2008 Oct; 50(5):667-77. PubMed ID: 18932130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepwise gatekeeping procedures in clinical trial applications.
    Dmitrienko A; Tamhane AC; Wang X; Chen X
    Biom J; 2006 Dec; 48(6):984-91. PubMed ID: 17240656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enhanced mixture method for constructing gatekeeping procedures in clinical trials.
    Kordzakhia G; Brechenmacher T; Ishida E; Dmitrienko A; Zheng WW; Li DF
    J Biopharm Stat; 2018; 28(1):113-128. PubMed ID: 29239689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized multiple contrast tests in dose-response studies.
    Ma S; McDermott MP
    Stat Med; 2020 Mar; 39(6):757-772. PubMed ID: 31793014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding MCP-MOD dose finding as a method based on linear regression.
    Thomas N
    Stat Med; 2017 Nov; 36(27):4401-4413. PubMed ID: 28879676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gatekeeping procedures in dose-response clinical trials based on the Dunnett test.
    Dmitrienko A; Offen W; Wang O; Xiao D
    Pharm Stat; 2006; 5(1):19-28. PubMed ID: 17080925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general multistage procedure for k-out-of-n gatekeeping.
    Xi D; Tamhane AC
    Stat Med; 2014 Apr; 33(8):1321-35. PubMed ID: 24307257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.